ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 学会発表・講演等
  2. 口頭発表

Tau PET findings of chronic traumatic encephalopathy (CTE) and late-life psychiatric diseases

https://repo.qst.go.jp/records/82821
https://repo.qst.go.jp/records/82821
43aeb2fb-2ef8-44c5-ad30-5c321c124813
Item type 会議発表用資料 / Presentation(1)
公開日 2021-05-13
タイトル
タイトル Tau PET findings of chronic traumatic encephalopathy (CTE) and late-life psychiatric diseases
言語
言語 eng
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_c94f
資源タイプ conference object
アクセス権
アクセス権 metadata only access
アクセス権URI http://purl.org/coar/access_right/c_14cb
著者 Keisuke, Takahata

× Keisuke, Takahata

WEKO 949568

Keisuke, Takahata

Search repository
Keisuke, Takahata

× Keisuke, Takahata

WEKO 949569

en Keisuke, Takahata

Search repository
抄録
内容記述タイプ Abstract
内容記述 Tau PET is a molecular imaging technique to detect accumulation of tau aggregates in neurodegenerative diseases non-invasively using a specific probe for tau. Our previous clinical studies using 11C-PBB3 have shown that abundance of tau pathology in the focal brain region is associated with a variety of psychiatric symptoms, including psychotic symptoms in late-life depression (Moriguchi et al., 2020) and long-term psychiatric outcomes of traumatic brain injury (TBI) (Takahata et al., 2019). These studies suggest that tau pathology in the brain is associated with the development of psychiatric symptoms. However, first-generation tau PET tracers have several issues that impede practical application, such as non-specific accumulation in the venous sinus, off-target binding, low image contrast and metabolic instability. 18F- APN-1607(18F-PM-PBB3) is second-generation tau PET tracer, which is characterized by less non-specific accumulation, higher image contrast, and metabolic stability than first-generation tau PET tracers. Our recent study showed that PET imaging using this tracer can capture tau pathology not only in Alzheimer’s disease (AD) but also in a wide range of non-AD tauopathies (Tagai et al., 2020). Therefore, 18F- APN-1607 is expected to be a powerful tool for exploring the pathology underlying psychiatric diseases.
In this lecture, we will show PET findings in a neurodegenerative disease due to TBI (chronic traumatic encephalopathy: CTE) with a focus on the case of boxers and late-life psychiatric disorders (late-life psychosis, late-life mood disorder). We also discuss techniques for accurate quantification of tau pathology using tau PET in chronic stage of TBI in consideration of unique topology of tau lesions in CTE.
会議概要(会議名, 開催地, 会期, 主催者等)
内容記述タイプ Other
内容記述 The 3rd Annual Workshop on APN-1607 (PM-PBB3)
発表年月日
日付 2020-12-11
日付タイプ Issued
戻る
0
views
See details
Views

Versions

Ver.1 2023-05-15 17:39:25.708126
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3